Solid results despite major economic challenges

Wednesday, January 31, 2024, Mainz, Germany

  • Sales increased to EUR 2.9 billion with products for the pharmaceutical, optics, and semiconductor industries driving growth

  • Substantial progress in climate protection goals made, while gaining recognition from multiple prestigious sustainability awards in 2023

  • Investments of over EUR 500 million planned for the current fiscal year

SCHOTT achieved solid results in the 2022/23 fiscal year: Despite numerous challenges, such as high energy costs, customer reticence, and global competitive pressure, the international technology group's global sales increased by four percent to EUR 2.9 billion, with an EBIT of EUR 413 million. "We are continuing to focus on innovation and sustainable growth. Our financial strength coupled with strategic investments allow us to face the challenges in the international market with confidence," says SCHOTT Chairman of the Board of Management, Dr Frank Heinricht.
Woman wearing safety gloves holding glass wafer.
Carrier wafers are one of many SCHOTT products that support the production of extremely powerful microchips. Unique properties of glass, such as thermal and mechanical stability, or an ultra-low flatness in geometrical properties, are trailblazing innovations and new products in semiconductor packaging. Photo: SCHOTT

SCHOTT's financial stability in the fiscal year 2022/23 is demonstrated, among other things, by a significant increase in its equity ratio from 51% to 63%, according to CFO Dr. Jens Schulte. The company’s net income of EUR 277 million, as well as the successful initial public offering (IPO) of SCHOTT Pharma AG & Co. KGaA at the end of September 2023, were contributing factors to these results. Gross proceeds of around EUR 935 million, gained from the placement of 23% of the ordinary shares on the public market, had a major impact on net liquidity.  Products and solutions for the pharmaceutical industry and high-end optics were important sales drivers. SCHOTT intends to use the proceeds to further invest in its ambitious sustainability commitment and strategic growth in Europe, the US, and China.

International production network expansion

In fiscal year 2022/23, the company continued to expand its international production network with around EUR 450 million of investments. Last year saw the groundbreaking ceremony for a new pharmaceutical production facility in Hungary, and the inauguration of a state-of-the-art diagnostics facility in the US. In addition, the company secured the necessary supply of alternatives to natural gas and important raw materials. This year, SCHOTT intends to invest another record sum of over EUR 500 million. Plans include expanding the production area of its optics competence center in Malaysia and constructing a climate-neutral administration and production building in Landshut, Bavaria. Its subsidiary SCHOTT Pharma plans to expand its manufacturing capacities, including a new production line for polymer syringes in Müllheim, Germany, a glass syringe plant in Hungary, and a new production site in Serbia. Furthermore, SCHOTT plans to strategically strengthen its business with a focus on the semiconductor industry.

Major progress on the path to sustainability

As an energy-intensive company, SCHOTT aims to achieve climate-neutral production by 2030. To that end, the company reached important milestones in the past fiscal year, including successful laboratory tests with hydrogen – a technology that will now be tested further in large-scale production this year. SCHOTT has also committed to the SBTi climate protection initiative, joined the United Nations Global Compact, and, with grant funding from the German Federal Ministry for the Environment and Climate Protection, plans to build its first electric melting tank for pharmaceutical tubing in Mitterteich, Bavaria by 2026. This clear commitment to greater sustainability was recognized with two German Sustainability Awards, including first place in the special Climate Transformation category.

Outlook: Maintaining stability while driving innovation

Building on a 140-year history of innovation, SCHOTT continues to focus on developing novel materials and products that advance science and industry. Specialty glass from SCHOTT not only enables breakthroughs in extremely sophisticated consumer electronics and technologies such as augmented reality but is a key partner in the development of future applications in the semiconductor industry, particularly those needed for the AI revolution.

Man holding AR glasses in his hand.

High-end optics were important sales drivers in 2023. SCHOTT sees great potential for the future in the area of augmented reality. Photo: SCHOTT

JPG   3.7 MB
Prefillable polymer syringes in Müllheim.

SCHOTT Pharma is expanding its manufacturing capacities for prefillable polymer syringes in Müllheim, Germany. In addition, the new glass syringe plant in Hungary is scheduled for completion later this year, and a new production site is being built in Serbia. Photo: SCHOTT

JPG   9.9 MB
Two men and a woman in work clothes with safety goggles at the test melt.

As part of its goal to achieve climate-neutral production by 2030, SCHOTT researchers are testing how they can melt glass with green electricity. Photo: SCHOTT

JPG   4.4 MB

About SCHOTT

International technology group SCHOTT produces high-quality components and advanced materials, including specialty glass, glass-ceramics, and polymers. Many SCHOTT products have high-tech applications that push technological boundaries, such as flexible glass in foldable smartphones, glass-ceramic mirror substrates in the world's largest telescopes, and laser glass in nuclear fusion. With their pioneering spirit, SCHOTT’s 17,100 employees in over 30 countries work as partners to industries such as healthcare, home appliances, consumer electronics, semiconductors, optics, astronomy, energy, and aerospace. In fiscal year 2023, SCHOTT generated 2.9 billion euros (3.0 billion USD) in sales. In addition to innovation, one of its important corporate goals is sustainability, where it is pursuing climate neutral production by 2030. SCHOTT was founded in 1884 and is headquartered in Mainz, Germany. The company belongs to the Carl Zeiss Foundation, which uses its dividends to promote science. Further information at SCHOTT.com

Contact us

For more information about this media release, please contact me.

Contact us
Rina Della Vecchia, Senior Marketing Communication Manager
Rina Della Vecchia

Senior Marketing Communication Manager